145 related articles for article (PubMed ID: 37837384)
1. TRIM29 promotes the progression of colorectal cancer by suppressing EZH2 degradation.
Chen Y; Ma J; Zhang M
Exp Biol Med (Maywood); 2023 Sep; 248(18):1527-1536. PubMed ID: 37837384
[TBL] [Abstract][Full Text] [Related]
2. RNA interference against TRIM29 inhibits migration and invasion of colorectal cancer cells.
Xu W; Xu B; Yao Y; Yu X; Cao H; Zhang J; Liu J; Sheng H
Oncol Rep; 2016 Sep; 36(3):1411-8. PubMed ID: 27430345
[TBL] [Abstract][Full Text] [Related]
3. Silencing of MBD2 and EZH2 inhibits the proliferation of colorectal carcinoma cells by rescuing the expression of SFRP.
Xie Y; Wang F; Yu J; Zhang J; Liu Y; Li M; Qi J
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34617573
[TBL] [Abstract][Full Text] [Related]
4. The carcinogenic complex lncRNA DUXAP8/EZH2/LSD1 accelerates the proliferation, migration and invasion of colorectal cancer.
Gong A; Huang Z; Ge H; Cai Y; Yang C
J BUON; 2019; 24(5):1830-1836. PubMed ID: 31786844
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer.
Jiang T; Tang HM; Lu S; Yan DW; Yang YX; Peng ZH
Med Oncol; 2013 Dec; 30(4):715. PubMed ID: 24078150
[TBL] [Abstract][Full Text] [Related]
6.
Guo J; Zhu H; Li Q; Dong J; Xiong W; Yu K
Aging (Albany NY); 2021 Apr; 13(8):11665-11677. PubMed ID: 33879635
[TBL] [Abstract][Full Text] [Related]
7. LncRNA-ANCR down-regulation suppresses invasion and migration of colorectal cancer cells by regulating EZH2 expression.
Yang ZY; Yang F; Zhang YL; Liu B; Wang M; Hong X; Yu Y; Zhou YH; Zeng H
Cancer Biomark; 2017; 18(1):95-104. PubMed ID: 27983539
[TBL] [Abstract][Full Text] [Related]
8. TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway.
Sun J; Zhang T; Cheng M; Hong L; Zhang C; Xie M; Sun P; Fan R; Wang Z; Wang L; Zhong J
J Exp Clin Cancer Res; 2019 Feb; 38(1):104. PubMed ID: 30813948
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-506-3p inhibits colorectal cancer cell proliferation through targeting enhancer of zeste homologue 2.
Ai L; Luo X; Yan X; Jiang S
Bioengineered; 2021 Dec; 12(1):4044-4053. PubMed ID: 34288823
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA DLX6-AS1 Regulates the Growth and Aggressiveness of Colorectal Cancer Cells Via Mediating the miR-26a/EZH2 Axis.
Kong WQ; Liang JJ; Du J; Ye ZX; Gao P; Liang YL
Cancer Biother Radiopharm; 2021 Nov; 36(9):753-764. PubMed ID: 32379493
[No Abstract] [Full Text] [Related]
11. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
[No Abstract] [Full Text] [Related]
12. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
[TBL] [Abstract][Full Text] [Related]
13. Hsa_circ_0071589 promotes carcinogenesis via the miR-600/EZH2 axis in colorectal cancer.
Yong W; Zhuoqi X; Baocheng W; Dongsheng Z; Chuan Z; Yueming S
Biomed Pharmacother; 2018 Jun; 102():1188-1194. PubMed ID: 29710537
[TBL] [Abstract][Full Text] [Related]
14. LINC01116 facilitates colorectal cancer cell proliferation and angiogenesis through targeting EZH2-regulated TPM1.
Liang W; Wu J; Qiu X
J Transl Med; 2021 Jan; 19(1):45. PubMed ID: 33499872
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of Long Noncoding RNA HOTAIR and EZH2 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Human Breast Cancer Cells.
Han L; Zhang HC; Li L; Li CX; Di X; Qu X
Cancer Biother Radiopharm; 2018 Aug; 33(6):241-251. PubMed ID: 30048163
[TBL] [Abstract][Full Text] [Related]
17. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
Tan ST; Liu SY; Wu B
Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of EZH2 expression is associated with the proliferation, apoptosis, and migration of SW620 colorectal cancer cells in vitro.
He SB; Zhou H; Zhou J; Zhou GQ; Han T; Wan DW; Gu W; Gao L; Zhang Y; Xue XF; Zhang LF; Fei M; Hu SQ; Yang XD; Zhu XG; Wang L; Li DC
Exp Biol Med (Maywood); 2015 Apr; 240(4):458-66. PubMed ID: 25005166
[TBL] [Abstract][Full Text] [Related]
19. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
20. miR-101 suppresses colon cancer cell migration through the regulation of EZH2.
Huang Z; Wu X; Li J
Rev Esp Enferm Dig; 2021 Apr; 113(4):255-260. PubMed ID: 33207890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
